Skip to main content
. 2014 Jul 1;105(7):897–904. doi: 10.1111/cas.12442

Figure 4.

Figure 4

Clonal heterogeneity correlated with poor prognosis. (a) Kaplan–Meier analysis to compare survival in mantle cell lymphoma patients with and without clonal heterogeneity. Patients with clonal heterogeneity demonstrated a poorer prognosis than those without. (b) Kaplan-Meier analysis in diffuse large B-cell lymphoma (DLBCL) patients. Patients with clonal heterogeneity demonstrated poorer prognosis than those without clonal heterogeneity.